Abstract:BACKGROUND: Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping is one of the most useful additional MRI parameters to improve diagnostic accuracy and is now often used in a multiparameric imaging setting for breast tumor detection and characterization.PURPOSE: To evaluate whether different ADC metrics can also be used for prediction of receptor status, proliferation rate, and molecular subtype in invasive breast cancer.STUDY TYPE: Retrospective.SUBJECTS: In all, 107 patients with invasive breast cancer met the inclusion criteria (mean age 57 years, range 32-87) and underwent multiparametric breast MRI.FIELD STRENGTH/SEQUENCE: 3 T, readout-segmented echo planar imaging (rsEPI) with IR fat suppression, dynamic contrast-enhanced (DCE) T<sub>1</sub> -weighted imaging, T<sub>2</sub> -weighted turbo-spin echo (TSE) with fatsat.ASSESSMENT: Two readers independently drew a region of interest on ADC maps on the whole tumor (WTu), and on its darkest part (DpTu). Minimum, mean, and maximum ADC values of both WTu and DpTu were compared for receptor status, proliferation rate, and molecular subtypes.STATISTICAL TESTS: Wilcoxon rank sum, Mann-Whitney U-tests for associations between radiologic features and histopathology; histogram and q-q plots, Shapiro-Wilk's test to assess normality, concordance correlation coefficient for precision and accuracy; receiver operating characteristics curve analysis.RESULTS: Estrogen receptor (ER) and progesterone receptor (PR) status had significantly different ADC values for both readers. Maximum WTu (P = 0.0004 and 0.0005) and mean WTu (P = 0.0101 and 0.0136) were significantly lower for ER-positive tumors, while PR-positive tumors had significantly lower maximum WTu values (P = 0.0089 and 0.0047). Maximum WTu ADC was the only metric that was significantly different for molecular subtypes for both readers (P = 0.0100 and 0.0132) and enabled differentiation of luminal tumors from nonluminal (P = 0.0068 and 0.0069) with an area under the curve of 0.685 for both readers.DATA CONCLUSION: Maximum WTu ADC values may be used to differentiate luminal from other molecular subtypes of breast cancer.LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:836-846.

Heterogeneity of Diffusion-Weighted Imaging in Tumours and the Surrounding Stroma for Prediction of Ki-67 Proliferation Status in Breast Cancer

Diffusion-weighted Imaging Features of Breast Tumours and the Surrounding Stroma Reflect Intrinsic Heterogeneous Characteristics of Molecular Subtypes in Breast Cancer

The correlation between diffusion weighted imaging with cervical cancer cell proliferation activity of PCNA and Ki-67

Analysis of DCE-MRI features in tumor and the surrounding stroma for prediction of Ki-67 proliferation status in breast cancer

Quantitative diffusion weighted imaging parameters in tumor and peritumoral stroma for prediction of molecular subtypes in breast cancer

Intratumor Heterogeneity of DCE-MRI Reveals Ki-67 Proliferation Status in Breast Cancer

Predicting of Ki-67 Expression Level Using Diffusion-Weighted and Synthetic Magnetic Resonance Imaging in Invasive Ductal Breast Cancer

Heterogeneity Of Tumor And Its Surrounding Stroma On Dce-Mri And Diffusion Weighted Imaging In Predicting Histological Grade And Lymph Node Status Of Breast Cancer

Diffusion-Weighted MRI for the Assessment of Molecular Prognostic Biomarkers in Breast Cancer

Can Diffusion-Weighted Imaging Predict Tumor Grade and Expression of Ki-67 in Breast Cancer? A Multicenter Analysis

Prediction and Prognosis of Biologically Aggressive Breast Cancers by the Combination of DWI/DCE-MRI and Immunohistochemical Tumor Markers.

The feasibility of intravoxel incoherent motion to indicate immunohistochemical characteristics in breast cancer

Multiparametric diffusion-weighted imaging in breast lesions: Association with pathologic diagnosis and prognostic factors.

DCE-MRI Texture Analysis with Tumor Subregion Partitioning for Predicting Ki-67 Status of Estrogen Receptor-Positive Breast Cancers.

Predictive Ability of DWI/ADC and DCE-MRI Kinetic Parameters in Differentiating Benign from Malignant Breast Lesions and in Building a Prediction Model.

Prediction of Histological Grade and Ki-67 Expression in Breast Cancer by DCE-MRI and DWI Features

Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps

Evaluating proliferation,invasion and prognosis of lymphoma with diffusion weighted imaging

Diffusion‐weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer

Apparent Diffusion Coefficient Cannot Predict Molecular Subtype and Lymph Node Metastases in Invasive Breast Cancer: a Multicenter Analysis

MR Diffusion Weighted Imaging with Background Signal Suppression in Breast Cancer